- ·Watch Glafabra Therapeutics: the Monday email on marks, rounds and moves
Glafabra Therapeutics funding history
No funding rounds for Glafabra Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Glafabra Therapeutics valuation
Glafabra Therapeutics's last known valuation is $65 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Glafabra Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Glafabra Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Glafabra Therapeutics
- What is Glafabra Therapeutics worth?
- Glafabra Therapeutics's last known valuation is $65.0M.
- How much has Glafabra Therapeutics raised?
- Glafabra Therapeutics has raised $200K in total funding across its recorded rounds.